JPRN-UMIN000001529已完成未知
Phase II trial of irinotecan plus cisplatin for pretreated patients with Ewing sarcoma and PNET - EFT-CPT-CDDP
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patient who have no indication for chemotherapy
研究者
相似试验
招募中
2 期
Phase II Study of cisplatin plus irinotecan for large cell neuroendocrine carcinomaarge cell neuroendocrine carcinomaJPRN-UMIN000004796ational Cancer Research Center Hospital East44
已完成
2 期
phase II study of irinotecan plus cisplatin followed by amrubicin in patients with extensive disease small-cell lung cancer.extensive disease small-cell lung cancerJPRN-C000000113West Japan Oncology Group45
已完成
2 期
Phase II study of nedaplatin plus irinotecan for stage III/IV squamous cell lung cancer (TORG0910)JPRN-UMIN000003330Thoracic Oncology Research Group (TORG)50
已完成
2 期
A phase II study of nedaplatin plus irinotecan for stage III/IV and EGFR mutation negative non-small cell lung cancer with high-risk factorsJPRN-UMIN000003622Kanagawa Cancer Center35
已完成
不适用
Phase I study of irinotecan and cisplatin with concurrent thoracic radiotherapy in patients with limited-disease small cell lung cancerCancerLung CancerISRCTN75771514Erasmus Medical Centre (The Netherlands)9